7-Ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease

Clinica Chimica Acta

Volumn 260, Issue 1, 1997, Pages 1-13

  Dyer, Robert G ^a   Stewart, Murray W ^a   Mitcheson, Janice ^a   George, K ^a   Alberti, M M ^a   Laker, Michael F ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

7 Ketocholesterol; Atherosclerosis; Diabetes; Lipoproteins; Malondialdehyde

Indexed keywords

7 OXOCHOLESTEROL; ALPHA TOCOPHEROL; ASCORBIC ACID; FREE RADICAL; LIPOPROTEIN; MALONALDEHYDE; THIOBARBITURIC ACID;

ADULT; AGED; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; FEMALE; HUMAN; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CHROMATOGRAPHY, GAS; DIABETES MELLITUS, TYPE 2; FREE RADICALS; HUMANS; KETOCHOLESTEROLS; LIPID PEROXIDES; LIPOPROTEINS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATION-REDUCTION; PERIPHERAL VASCULAR DISEASES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA;

EID: 0030907422     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(96)06499-6     Document Type: Article

References (31)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Diabetes 1974;23:105-111.
2. Jarret RJ, Keen H. Diabetes and atherosclerosis. In: Jarret RJ, Keen H, eds. Complications of diabetes. London: Arnold, 1975;179-204.
3. Chisholm GM, Irwin KG, Penn MS. Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes. Diabetes 1992;41:61-66.
4. Baynes JW. Role of oxidative stress in development of complications of diabetes. Diabetes 1991;40:405-412.
5. Sato Y, Hotta N, Sakamoto N et al. Lipid peroxide level in plasma of diabetic patients. Biochem Med 1979;21:104-107.
6. Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnett AH. Increased diene conjugates in diabetic subjects with microangiopathy. Diabetic Med 1987;4:452-456.
7. Velásquez E, Winocour PH, Kesteven P, Alberti KGMM, Laker MF. Relation of lipid peroxides to macrovascular disease in Type 2 diabetes. Diabetic Med 1991;8:752-758.
8. Mooradian AD. Increased serum conjugated dienes in elderly diabetic patients. J Am Geriatr Soc 1991;39:571-574.
9. Collier A, Jackson M, Dawkes RM, Bell D, Clarke BF. Reduced free-radical activity detected by decreased diene conjugates in insulin-dependent diabetic patients. Diabetic Med 1988;5:747-749.
10. Gutteridge JMC, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990;15:129-135.
11. Knight JA, Pieper RK, McLellan L. Specificity of the TBA reaction: its use in studies of lipid peroxidation. Clin Chem 1988;34:2433-2438.
12. Jialal I, Freeman DA, Grundy SM. Varying susceptibility of different low density lipoproteins to oxidative modification. Arterioscler Thromb 1991;11:482-488.
13. Morin RJ, Peng SK. The role of cholesterol oxidation products in the pathogenesis of atherosclerosis. Ann Clin Lab Sci 1989;19:225-237.
14. Bradley DW, Maynard JE, Emery G. Comparison of ascorbic acid concentrations in whole blood obtained by venepuncture or by finger prick. Clin Chem 1972;18:968-970.
15. Catignani GL. An HPLC method for the simultaneous determination of retinol and α-tocopherol in plasma or serum. Methods Enzymol 1986;123:215-219.
16. Stewart MW, Laker MF, Dyer RG, Game F, Mitcheson J, Winocour PH, Alberti KGMM. Lipoprotein compositional abnormalities and insulin resistance in Type 2 diabetic patients with mild hyperlipidaemia. Arterioscler Thromb 1993;13:1046-1052.
17. Babiy AV, Gebicki JM, Sullivan DR. Vitamin E content and LDL oxidizability by free radicals. Atherosclerosis 1990:81:175-182.
18. Addis B, Emmanuel HA, Bergmann SD, Zavoral JH. Capillary GC quantification of cholesterol oxidation products in plasma lipoproteins of fasted humans. Free Radic Biol Med 1989;7:179-182.
19. Dyer RG, Hetherington, CS, Alberti KGMM, Laker MF. Simultaneous measurement of phytosterols (campesterol and β-sitosterol) and 7-ketocholesterol in human lipoproteins by capillary column gas chromatography. J Chromatogr 1995;663:1-7.
20. Stringer MD, Gorog PG, Freeman A, Kakkar VV. Lipid peroxides and atherosclerosis. Br Med J 1989;298:281-284.
21. Richard M-J, Portal B, Meo J, Coudray C, Hadjian A, Favier A. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin Chem 1992;38:704-709.
22. Nishigaki I, Hagihara M, Tsunekawa H, Maseki M, Yagi K. Lipid peroxide levels of serum lipoprotein fractions in diabetic patients. Biochem Med 1981;25:373-378.
23. Smith LL. Autoxidation of cholesterol. New York: Plenum, 1981.
24. Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993;98:1-9.
25. Jacobsen MS, Price MG, Shamoo AE, Heald FP. Atherogenesis in White Carneau pigeons. Atherosclerosis 1985;57:209-217.
26. Dyer RG, Stewart MW, Laker MF. Type 2 diabetes and peripheral vascular disease are characterised by reduced markers of dietary cholesterol absorption. Diabetic Med 1993;10(Suppl. 1):S14.
27. Som S, Basu S, Mukherjee D, Deb S, Choudary R, Mukherjee S, Chatteijee SN, Chatterjee IB. Ascorbic acid metabolism in diabetes mellitus. Metabolism 1981;30:572-577.
28. Sinclair AJ, Girling AJ, Gray L, Le Guen C, Lunec J, Barnett AH. Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia 1991;34:171-175.
29. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53:326S-334S.
30. Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 1991;337:1-5.
31. Steinberg DS, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.